Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Left-atrial Fibrosis in Persistent Atrial Fibrillation, Sleep Apnoe and Primary Aldosteronism

NCT07857044 is registered in ClinicalTrials.gov with Christina Berr. MD as lead sponsor.

NCT NCT07857044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07857044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Left-atrial Fibrosis in Persistent Atrial Fibrillation, Sleep Apnoe and Primary Aldosteronism
Lead sponsor
Christina Berr. MD
Phase
Observational
Overall status
Recruiting
Start date
March 31, 2023
Completion date
December 31, 2029
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, primary aldosteronism, sleep apnea